Your browser doesn't support javascript.
loading
Effects of long-term intravenous ibandronate therapy on skeletal-related events, survival, and bone resorption markers in patients with advanced multiple myeloma.
Menssen, Hans D; Sakalová, Adriana; Fontana, Aurélie; Herrmann, Zuzana; Boewer, Christian; Facon, Thierry; Lichinitser, Michail R; Singer, C R J; Euller-Ziegler, Liana; Wetterwald, Marc; Fiere, Denis; Hrubisko, Mikulás; Thiel, Eckhard; Delmas, Pierre D.
Affiliation
  • Menssen HD; Department of Hematology and Oncology, Benjamin Franklin Klinik der Freien Universität, and St Hedwigs-Krankenhaus, Berlin, Germany. hmenssen@zedat.fu-berlin.de
J Clin Oncol ; 20(9): 2353-9, 2002 May 01.
Article in En | MEDLINE | ID: mdl-11981007
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Diphosphonates / Multiple Myeloma Type of study: Clinical_trials / Etiology_studies Limits: Female / Humans / Male / Middle aged Language: En Journal: J Clin Oncol Year: 2002 Type: Article Affiliation country: Germany
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Diphosphonates / Multiple Myeloma Type of study: Clinical_trials / Etiology_studies Limits: Female / Humans / Male / Middle aged Language: En Journal: J Clin Oncol Year: 2002 Type: Article Affiliation country: Germany